Risk factors
Moderna (MRNA) risk factors
Item 1A of every Moderna, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors73 risks10 new9 dropped27 reworded
Regulatory uncertainty, vaccine demand, pricing policy and trade restrictions now receive greater emphasis.
Filed Feb 20, 2026 - FY2024 10-K risk factors72 risks
Moderna faces significant risks from revenue uncertainty in COVID and RSV vaccines and intense competition from larger pharmaceutical companies. The company incurred net losses of $3.6 billion in 2024 and $4.7 billion in 2023.
Filed Feb 21, 2025